教室紹介

2020年業績集

受賞

  1. 第108回日本泌尿器科学会総会 International Session Award, Renal Tumor
    Hajime Tanaka, Wataru Shimada, Shohei Fukuda, Hiroshi Fukushima, Sho Uehara, Shingo Moriyama, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii. Significance of tumor shape irregularity in predicting oncologic outcomes of clinically localized renal cell carcinoma. 第108回日本泌尿器科学会総会 2020年12月22日

  2. 第34回日本泌尿器内視鏡学会総会　学会賞（ビデオ部門）
    森山 真吾, 横山 みなと, 木田 智, 田畑 龍治, 川島 洋平, 篠崎 哲男, 小川 一栄, 福田 護, 藤井 靖久, 佐藤 聡. 仙骨腟固定術の腟前壁剥離に難渋した一例：微細構造を意識した剥離についての一考察. 第34回日本泌尿器内視鏡学会総会 2020年11月19日

  3. 第634回日本泌尿器科学会東京地方会　ベストプレゼンテーション賞
    山口 良友, 横山 みなと, 竹本 暁, 島田 航, 松本 卓矢, 三谷 康輝, 片岡 円, 中村 祐基, 范 博, 内田 裕將, 戸出 真宏, 福田 翔平, 福島 啓司, 安田 庸輔, 上原 翔, 田中 一, 吉田 宗一郎, 松岡 陽, 藤井 靖久. SDH染色が陰性であった悪性後腹膜傍神経節腫にSDH欠損腎細胞癌の合併を認めた1例. 第634回日本泌尿器科学会東京地方会 2020年12月18日

原著

  1. Waseda Y, Kobayashi S, Kanda E, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model. Clin Genitourin Cancer, 18(2): e62-70, 2020. PubMed

  2. Kijima T, Tanaka H, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Kihara K, Fujii Y. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy. Clin Genitourin Cancer, 18(4): 268-273.e2, 2020.PubMed

  3. Yoshida S, Takahara T, Ishii C, Arita Y, Waseda Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer. Clin Genitourin Cancer, 18(4): e391-e396, 2020.PubMed

  4. Tanaka H, Fukushima H, Kijima T, Nakamura Y, Yajima S, Uehara S, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer. Int J Urol, 27(3): 236-243, 2020.PubMed

  5. Fukushima H, Saito K, Yasuda Y, Tanaka H, Patil D, Cotta BH, Patel SH, Master VA, Derweesh IH, Fujii Y. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). Clin Genitourin Cancer, 18(2):111-116.e1, 2020.PubMed

  6. Kijima T, Ito M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Treatment-induced changes in levels of brain natriuretic peptide in prostate cancer patients receiving gonadotropin-releasing hormone antagonists or agonists. Int J Urol, 27(4):354-355, 2020. PubMed

  7. Yoshida S, Taniguchi N, Moriyama S, Matsuoka Y, Saito K, Fujii Y. Application of virtual reality in patient explanation of magnetic resonance imaging-ultrasound fusion prostate biopsy. Int J Urol, 27(5):471-472, 2020.PubMed

  8. Fukushima H, Inoue M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications. Clin Genitourin Cancer, S1558-7673(20)30038-0, 2020.PubMed

  9. Nakamura Y, Yokoyama M, Yoshida S, Tanaka H, Kijima T, Ishioka J, Matsuoka Y, Saito K, Minami I, Yoshimoto T, Naito S, Ogawa Y, Yamada T, Uchida S, Fujii Y. Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome. Int J Urol, 27(5):395-400, 2020.PubMed

  10. Matsumoto S, Kijima T, Matsuoka Y, Yamamoto M, Fujii Y. A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab. Eur J Cancer, 131:104-107, 2020.PubMed

  11. Yokoyama M, Masuda H, Ito M, Waseda Y, Moriyama S, Toide M, Uchida Y, Uehara S, Kijima T, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation. Low Urin Tract Symptoms.12(3):240-244, 2020.PubMed

  12. Yoshida S, Takahara T, Arita Y, Toda K, Yoshimura R, Fujii Y. Patterns of failure after progressive site-directed therapy in oligo-progressive castration-resistant prostate cancer. Int J Urol, 27(7):634-635, 2020.PubMed

  13. Kaneko K, Yoshida S, Yamamoto K, Arita Y, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Saito K, Fujii Y. Renal epithelioid angiomyolipoma: Incidence in a Japanese cohort and diagnostic utility of diffusion-weighted magnetic resonance imaging. Int J Urol, 27(7):599-604, 2020.PubMed

  14. Izumi K, Saito K, Nakayama T, Fukuda S, Fukushima H, Uehara S, Koga F, Yonese J, Kageyama Y, Fujii Y. Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma. Int J Urol, 27(8):657-662., 2020.PubMed

  15. Matsuoka Y, Uehara S, Yoshida S, Tanaka H, Tanaka H, Kijima T, Yokoyama M, Ishioka J, Saito K, Fujii Y. Value of extra-target prostate biopsy for the detection of magnetic resonance imaging-missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance-ultrasound fusion images. Int J Urol. 27(9):760-766, 2020.PubMed

  16. Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report. Anticancer Drugs, 31(8):866-871, 2020.PubMed

  17. Yajima S, Ooeda T, Inoue M, Suzuki H, Matsumoto S, Masuda H. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE), improved following surgical resection of prostatic carcinoma: A case report. Urol Case Rep, 32:101232. 2020.PubMed

  18. Kobayashi M, Yokoyama M, Inoue M, Fujii Y. Undifferentiated prostate cancer treated with docetaxel. IJU Case Rep, 3(4):125-127, 2020.PubMed

  19. Fujiwara M, Komai Y, Yuasa T, Numao N, Yamamoto S, Fukui I, Yonese J. Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high. IJU Case Rep, 3(2):62-64, 2020.PubMed

  20. Fukushima H, Kijima T, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Saito K, Matsubara N, Numao N, Sakai Y, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer Med. 9(22):8355-8363, 2020.PubMed

  21. Sano Y, Fujiwara M, Yuasa T, Komai Y, Yamamoto T, Kohno A, Nakao M, Inamura K, Yonese J. Testicular seminoma with a progressing pulmonary nodule and mediastinal lymphadenopathy without retroperitoneal metastasis. IJU Case Rep. 3(5):211-214, 2020.PubMed

  22. Fujiwara M, Kawamura N, Okuno T. Renal function outcomes in the early and intermediate phases after radical cystectomy by ileal conduit. J Rural Med. 15(4):178-182, 2020.PubMed

  23. Fujiwara M, Yuasa T, Komai Y, Numao N, Yamamoto S, Fukui I, Yonese J. Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan. Target Oncol. 15(5):635-643, 2020.PubMed

  24. Soma T, Yokoyama M, Uchida Y, Kirimura S, Tanaka H, Yoshida S, Matsuoka Y, Fujii Y. Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report. Int Cancer Conf J. 10(1):20-23, 2020.PubMed